Sorafenib in patients with metastatic renal cell carcinoma refractory to either sunitinib or bevacizumab: Editorial comment

Samir S. Taneja

    Research output: Contribution to journalComment/debate

    Original languageEnglish (US)
    Number of pages1
    JournalJournal of Urology
    Volume185
    Issue number3
    DOIs
    StatePublished - Mar 2011

    ASJC Scopus subject areas

    • Urology

    Cite this